A Study to Assess the Efficacy, Safety, and Pharmacokinetics of Debio 4326 in Pediatric Participants With Central Precocious Puberty (LIBELULA™ Clinical Trial)
Debiopharm International SA · Central Precocious Puberty
Phase 3
Active, not recruiting
56
2026-07